Scientific article
English

Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment

Published in

Transplantation, vol. 98, no. 9, p. 1013-1018

Publication date

2014

Abstract

Cytomegalovirus (CMV) replication has been associated with more risk for solid organ graft rejection. We wondered whether this association still holds when patients at risk receive prophylactic treatment for CMV.

Citation (ISO format)

STERN, Martin et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. In: Transplantation, 2014, vol. 98, n° 9, p. 1013–1018. doi: 10.1097/TP.0000000000000160

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0041-1337
689views
0downloads

Technical informations

Creation

11/11/2014 15:16:00

First validation

11/11/2014 15:16:00

Update

08/11/2024 08:34:41

Status update

08/11/2024 08:34:41

Last indexation

08/11/2024 08:37:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated